ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2964

Thromboangiitis Obliterans (Buerger’s disease) : An Observational Study of 174 Patients

Alexandre LE JONCOUR1, Simon Soudet2, Hélène Maillard2, Fabien Koskas3, Philippe Cluzel4, Eric Hachulla5, Pierre-Yves Hatron5, Patrice Cacoub1, Marc Lambert2 and David Saadoun1, 1Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière, Département de Médecine Interne et d’Immunologie clinique, DHU i2B, Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris 6, Paris, France, Paris, France, 2Department of internal medecine, Hôpital Claude Huriez, CHRU Lille, France, Lille, France, 3Department of vascular surgery, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, 4Department of cardiovascular imagery, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié Salpétrière, 83 Boulevard de l'Hôpital, 75013, Paris, France., Paris, France, 5CHU Lille, Département de Médecine Interne et Immunologie Clinique, F-59000 Lille, France, Lille, France

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: Thrombosis, tobacco use and vasculitis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis - Poster III: Rarer Vasculitides

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Buerger’s disease or thromboangiitis obliterans (TAO) is a nonatherosclerotic segmental inflammatory disease of small- and medium-sized arteries of the distal extremities. This disease mainly affect young male tobacco users but the pathophysiology remains unknown. Most series of TAO come from India and Japan. Herein, we aim report to describe clinical presentation, treatment and long-term outcome in a large cohort of TAO.

Methods: We reviewed the charts of 174 [136 (78,2%) male, sex ratio 3.7, mean age at diagnosis of 38,4 years] consecutive french patients with TAO criteria from two french university center of internal medicine diagnosed between 1967 to 2015.

Results: The mean time between onset of symptoms and diagnosis was of 2.5 ±0.7years. One hundred seventy one (98.3%) patients were tobacco users with a mean consumption of 23.4 pack-years and 34 (19.5%) were cannabis consumers. At diagnosis, 15 patients (8.7%) had deep vein thrombosis, 39 (22.5%) superficial vein thrombosis, 76 (43.9%) Raynaud’s phenomenon and 14 (8%) arthralgia. Ischaemia of lower limbs, upper limbs and upper-lower limb were found in 98/173 (56.6%), 44/173 (25.4%) and in 18/173 (10.4%) patients, respectively. After a median follow-up of 3 (IQ25 :1 ; IQ 75 8,8) years, 89/171 (52%) had stopped their tobacco consumption and 26/34 (78.8%) their cannabis consumption. One hundred patients (57.4%) were treated by aspirin alone, 33(19%) by clopidogrel alone and 33 (19%) with both treatment. Ninety five (54.6%) had statins, 53 (30.5%) calcic inhibitors, 91 (52.3%) oral vasodilatators, 28 (16.1%) conversion enzyme inhibitors and 117 patients (67.2%) received at least one infusion of ilomedine. Forty five patients (25.9%) had at least one vascular intervention and 12/45 (26.7%) had an amputation. At the end of follow up, 104/169 patients (61.5%) were asymptomatic, 140/174 (80.5%) were amputation free. Among patient with amputation, 15/34 (44.1%) patients had more than one amputation. Mean time between diagnosis and first amputation was of 2.5 years. Two patients died at the end of folow-up.

Conclusion: TAO is a rare vasculitis, with few data coming from western countries. Functional prognosis is very poor with up to 20% of amputation at 3 years.


Disclosure: A. LE JONCOUR, None; S. Soudet, None; H. Maillard, None; F. Koskas, None; P. Cluzel, None; E. Hachulla, None; P. Y. Hatron, None; P. Cacoub, None; M. Lambert, None; D. Saadoun, None.

To cite this abstract in AMA style:

LE JONCOUR A, Soudet S, Maillard H, Koskas F, Cluzel P, Hachulla E, Hatron PY, Cacoub P, Lambert M, Saadoun D. Thromboangiitis Obliterans (Buerger’s disease) : An Observational Study of 174 Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/thromboangiitis-obliterans-buergers-disease-an-observational-study-of-174-patients/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2016

ACR Meeting Abstracts - https://acrabstracts.org/abstract/thromboangiitis-obliterans-buergers-disease-an-observational-study-of-174-patients/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology